logo
Select company
Select metric
Ticker Information

Ticker

ABCL

Company Name

ABCELLERA BIOLOGICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABCELLERA BIOLOGICS INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABCL - EV/FCF Historical data
DateEnterprise ValueEnterprise Value over Free Cash FlowFree Cash Flow
6/30/2025$ 1.29B0$ -138.99M
3/31/2025$ 478.9M0$ -143.29M
12/31/2024$ 749.54M0$ -186.95M
9/30/2024$ 768.24M0$ -197.36M
6/30/2024$ 732.94M0$ -170.4M
3/31/2024$ 1.11B0$ -127.63M
12/31/2023$ 1.47B0$ -120.82M
9/30/2023$ 1.16B0$ -68.2M
6/30/2023$ 1.89B0$ -187.06M
3/31/2023$ 1.77B28.54$ 61.93M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABCELLERA BIOLOGICS INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
  • Over the past 5 years, ABCELLERA BIOLOGICS INC's average EV/FCF has been 76.22.
  • The median EV/FCF for ABCELLERA BIOLOGICS INC during this period was 13.6
  • ABCELLERA BIOLOGICS INC reached its highest EV/FCF over the past 5 years at 507.2.
  • The lowest EV/FCF recorded by ABCELLERA BIOLOGICS INC in the same timeframe 8.16

Definition of Enterprise Value over Free Cash Flow

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
EV / FCF
(=) EV/FCF
EV/FCF for ABCELLERA BIOLOGICS INC is calculated as follows: EV [ $ 0 ] / FCF [ $ -1.3M ]
(=) EV/FCF [ 0 ]

ABCL - Enterprise Value over Free Cash Flow, Last 5 years

8.16

Minimum

Mar 31, 2022

507.2

Maximum

Dec 31, 2020

76.22

Average

13.6

Median

EV/FCF Benchmark Analysis

The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.46 with a standard deviation of 16.15.
The following table provides additional summary stats:
EV/FCF in the Market:
filtered constituents2.2K
min0.05
max77.98
average23.46
median19.08
std16.15